Angiotensin-converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARBs) may be safe for COVID-19 patients

BACKGROUND: To investigate the effects of angiotensin-converting enzyme inhibitor (ACEI) and angiotensin receptor blockers (ARBs) administration to hypertension patients with the coronavirus disease 2019 (COVID-19) induced pneumonia. METHODS: We recorded the recovery status of 67 inpatients with hyp...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Wenjun, Zhao, Xiaohui, Wei, Wei, Fan, Weiwang, Gao, Kai, He, Shengxiu, Zhuang, Xijing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829637/
https://www.ncbi.nlm.nih.gov/pubmed/33494713
http://dx.doi.org/10.1186/s12879-021-05821-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829637/
https://www.ncbi.nlm.nih.gov/pubmed/33494713
http://dx.doi.org/10.1186/s12879-021-05821-5

Ejemplares similares